{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:50:17Z","timestamp":1785790217788,"version":"3.56.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Progressive supranuclear palsy (PSP) is a tauopathy marked by widespread tau aggregation and prominent monoaminergic dysfunction, yet the relationship between regional tau burden and monoaminergic impairment remains unclear. In this study, we determine whether regional tau burden is associated with nigrostriatal monoaminergic dysfunction in PSP using PET imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>\n                      A subset of 20 patients with PSP and monoaminergic impairment, identified by\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-DTBZ PET, was recruited and subsequently underwent\n                      <jats:sup>18<\/jats:sup>\n                      F-APN-1607 PET to assess tau deposition. All images were spatially normalized and analyzed based on predefined volumes of interest. Erosion-based cerebral white matter was used as the reference region to calculate standardized uptake value ratios (SUVRs) for\n                      <jats:sup>18<\/jats:sup>\n                      F-APN-1607 PET.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The SUVRs of\n                      <jats:sup>18<\/jats:sup>\n                      F-APN-1607 PET differed significantly between patients with PSP and healthy controls in the globus pallidus, substantia nigra, subthalamus nucleus, and red nucleus, while a significant difference in\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-DTBZ SUVRs was observed in all the striatal regions and substantia nigra. Regression analysis discovered negative associations between tau load and monoaminergic disruption in the putamen and caudate, whereas tau accumulation in the substantia nigra was not significantly associated with nigrostriatal impairment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The pallido-nigro-luysian axis and nigrostriatal system serve as sensitive targets for detecting tau deposition and monoaminergic disruption in PSP. Local striatal tau pathology and tau burden were associated with monoaminergic disruption in PSP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006594","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:09:24Z","timestamp":1783346964000},"page":"764-770","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Striatal Tau Pathology Underlies Monoaminergic Disruption in Progressive Supranuclear Palsy"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1431-7389","authenticated-orcid":false,"given":"Chong","family":"Dong","sequence":"first","affiliation":[{"name":"Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3458-1363","authenticated-orcid":false,"given":"Jing-Hong","family":"Ma","sequence":"additional","affiliation":[{"name":"Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wen","family":"Qiao","sequence":"additional","affiliation":[{"name":"Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7192-4656","authenticated-orcid":false,"given":"Wen-Qi","family":"Xu","sequence":"additional","affiliation":[{"name":"Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu-Qin","family":"Gu","sequence":"additional","affiliation":[{"name":"XingImaging LLC, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4247-184X","authenticated-orcid":false,"given":"Olivier","family":"Barret","sequence":"additional","affiliation":[{"name":"Laboratory of Neurodegenerative Diseases, Paris-Saclay University Paris-Saclay, CEA, CNRS, MIRCen, Fontenay-aux-Roses, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles D.","family":"Tamagnan","sequence":"additional","affiliation":[{"name":"XingImaging LLC, New Haven, CT"},{"name":"National Clinical Research Center for Geriatric Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Mao","sequence":"additional","affiliation":[{"name":"Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er-He","family":"Xu","sequence":"additional","affiliation":[{"name":"Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0425-3921","authenticated-orcid":false,"given":"Jie","family":"Lu","sequence":"additional","affiliation":[{"name":"Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4620-1268","authenticated-orcid":false,"given":"Piu","family":"Chan","sequence":"additional","affiliation":[{"name":"Neurology"},{"name":"National Clinical Research Center for Geriatric Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5787-1163","authenticated-orcid":false,"given":"Shu-Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"R1-20260803","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"key":"R2-20260803","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches","volume":"16","author":"Boxer","year":"2017","journal-title":"Lancet Neurol"},{"key":"R3-20260803","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-051222-120750","article-title":"Neurodegenerative disease tauopathies","volume":"19","author":"Creekmore","year":"2024","journal-title":"Annu Rev Pathol"},{"key":"R4-20260803","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol"},{"key":"R5-20260803","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/mds.28188","article-title":"Synaptic loss in primary tauopathies revealed by [(11) C]UCB-J positron emission tomography","volume":"35","author":"Holland","year":"2020","journal-title":"Mov Disord"},{"key":"R6-20260803","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/jamaneurol.2020.2526","article-title":"Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy","volume":"77","author":"Brendel","year":"2020","journal-title":"JAMA Neurol"},{"key":"R7-20260803","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.28672","article-title":"Clinical utility of (18) F-APN-1607 Tau PET imaging in patients with progressive supranuclear palsy","volume":"36","author":"Li","year":"2021","journal-title":"Mov Disord"},{"key":"R8-20260803","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40035-026-00545-5","article-title":"Tau conformation, distribution and PET imaging correlations in progressive supranuclear palsy","volume":"15","author":"Dong","year":"2026","journal-title":"Transl Neurodegener"},{"key":"R9-20260803","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0969-8051(97)00101-7","article-title":"In vivo radiotracers for vesicular neurotransmitter transporters","volume":"24","author":"Kilbourn","year":"1997","journal-title":"Nucl Med Biol"},{"key":"R10-20260803","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cpet.2010.02.001","article-title":"(18)F-AV-133: a selective VMAT2-binding radiopharmaceutical for PET imaging of dopaminergic neurons","volume":"5","author":"Hefti","year":"2010","journal-title":"PET Clin"},{"key":"R11-20260803","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1093\/brain\/awr233","article-title":"Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson\u2019s disease","volume":"134","author":"Nandhagopal","year":"2011","journal-title":"Brain"},{"key":"R12-20260803","doi-asserted-by":"crossref","first-page":"931015","DOI":"10.3389\/fnagi.2022.931015","article-title":"Diagnostic value of striatal (18)F-FP-DTBZ PET in Parkinson\u2019s disease","volume":"14","author":"Liu","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"R13-20260803","doi-asserted-by":"crossref","first-page":"17631","DOI":"10.1038\/s41598-020-74495-x","article-title":"Reduced striatal vesicular monoamine transporter 2 in REM sleep behavior disorder: imaging prodromal parkinsonism","volume":"10","author":"Beauchamp","year":"2020","journal-title":"Sci Rep"},{"key":"R14-20260803","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamaneurol.2014.290","article-title":"Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography","volume":"71","author":"Hsiao","year":"2014","journal-title":"JAMA Neurol"},{"key":"R15-20260803","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/mds.29769","article-title":"Striatal and extrastriatal monoaminergic disruption in progressive supranuclear palsy","volume":"39","author":"Ma","year":"2024","journal-title":"Mov Disord"},{"key":"R16-20260803","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2967\/jnumed.110.078196","article-title":"Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent","volume":"51","author":"Lin","year":"2010","journal-title":"J Nucl Med"},{"key":"R17-20260803","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nucmedbio.2010.01.002","article-title":"Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats","volume":"37","author":"Tsao","year":"2010","journal-title":"Nucl Med Biol"},{"key":"R18-20260803","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fnins.2020.00604","article-title":"Associations of [(18)F]-APN-1607 Tau PET binding in the brain of Alzheimer\u2019s disease patients with cognition and glucose metabolism","volume":"14","author":"Lu","year":"2020","journal-title":"Front Neurosci"},{"key":"R19-20260803","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1002\/hbm.25556","article-title":"HybraPD atlas: towards precise subcortical nuclei segmentation using multimodality medical images in patients with Parkinson disease","volume":"42","author":"Yu","year":"2021","journal-title":"Hum Brain Mapp"},{"key":"R20-20260803","doi-asserted-by":"crossref","first-page":"116189","DOI":"10.1016\/j.neuroimage.2019.116189","article-title":"Automated anatomical labelling atlas 3","volume":"206","author":"Rolls","year":"2020","journal-title":"Neuroimage"},{"key":"R21-20260803","doi-asserted-by":"crossref","first-page":"117462","DOI":"10.1016\/j.neuroimage.2020.117462","article-title":"Regionconnect: rapidly extracting standardized brain connectivity information in voxel-wise neuroimaging studies","volume":"225","author":"Qi","year":"2021","journal-title":"Neuroimage"},{"key":"R22-20260803","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"R23-20260803","doi-asserted-by":"crossref","first-page":"20s","DOI":"10.2967\/jnumed.121.263196","article-title":"Tau PET imaging in neurodegenerative disorders","volume":"63","author":"Groot","year":"2022","journal-title":"J Nucl Med"},{"key":"R24-20260803","doi-asserted-by":"crossref","first-page":"118259","DOI":"10.1016\/j.neuroimage.2021.118259","article-title":"Selecting software pipelines for change in flortaucipir SUVR: balancing repeatability and group separation","volume":"238","author":"Schwarz","year":"2021","journal-title":"Neuroimage"},{"key":"R25-20260803","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","article-title":"Distribution patterns of tau pathology in progressive supranuclear palsy","volume":"140","author":"Kovacs","year":"2020","journal-title":"Acta Neuropathol"},{"key":"R26-20260803","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00259-022-06104-0","article-title":"(18)F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy","volume":"50","author":"Liu","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R27-20260803","doi-asserted-by":"crossref","first-page":"998255","DOI":"10.3389\/fnagi.2022.998255","article-title":"Striatal dopaminergic lesions contributed to the disease severity in progressive supranuclear palsy","volume":"14","author":"Chen","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"R28-20260803","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1021\/acschemneuro.3c00437","article-title":"Insight into the binding of first- and second-generation PET tracers to 4R and 3R\/4R tau protofibrils","volume":"14","author":"Li","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"R29-20260803","doi-asserted-by":"crossref","first-page":"awag136","DOI":"10.1093\/brain\/awag136","article-title":"Neuropathological correlates of age and sex differences in 18F-flortaucipir PET","volume":"20","author":"Coomans","year":"2026","journal-title":"Brain"},{"key":"R30-20260803","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00259-024-06637-6","article-title":"Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies","volume":"51","author":"Ferschmann","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R31-20260803","doi-asserted-by":"crossref","first-page":"e75952","DOI":"10.1371\/journal.pone.0075952","article-title":"Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS ONE"},{"key":"R32-20260803","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/RLU.0000000000006254","article-title":"18 F-FDG, 18 F-FP-CIT, and 18 F-Florzolotau PET imaging in progressive supranuclear palsy: region-specific correlations between glucose metabolism, dopaminergic function, and tau pathology","volume":"51","author":"Liang","year":"2026","journal-title":"Clin Nucl Med"},{"key":"R33-20260803","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/s41593-025-01992-5","article-title":"Evidence for trans-synaptic propagation of oligomeric tau in human progressive supranuclear palsy","volume":"28","author":"McGeachan","year":"2025","journal-title":"Nat Neurosci"},{"key":"R34-20260803","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JAD-160119","article-title":"Mini-Mental State Examination in elderly Chinese: a population-based normative study","volume":"53","author":"Li","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"R35-20260803","doi-asserted-by":"crossref","first-page":"689456","DOI":"10.1155\/2014\/689456","article-title":"The influence of education on Chinese version of Montreal Cognitive Assessment in detecting amnesic mild cognitive impairment among older people in a Beijing rural community","volume":"2014","author":"Zhou","year":"2014","journal-title":"ScientificWorldJournal"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:02:18Z","timestamp":1785787338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006594","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"2026-04-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}